Clinical Trials Logo

Autistic Disorder clinical trials

View clinical trials related to Autistic Disorder.

Filter by:

NCT ID: NCT03924973 Recruiting - Autism Clinical Trials

3 Year Follow up Study of the IDEA Population

IDEA2SCOLA
Start date: April 17, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to assess the efficiency of early treatment for ASD children 5 years after initial treatment. The early treatment implemented was 12 hours per week of ESDM versus treatment as usual during 2 years. This was done as an RCT, called IDEA. Children will now be included in IDEA-2 SCOLA, a three year follow up study.

NCT ID: NCT03919721 Not yet recruiting - Autistic Disorder Clinical Trials

Field Test of Motivity.Net Software for Data Collection During Behavioral Interventions

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

This is a study funded by a Phase II SBIR to build and test the feasibility of a new software prototype for delivering evidence-based behavioral therapy treatment for autism. The software, called Motivity.net, will be used by behavioral therapy provider groups across the country to manage the intensive data collection and analysis workflow associated with Applied Behavioral Analysis (ABA) and related therapies, which are becoming standard-of-care treatment for children with autism.

NCT ID: NCT03912896 Completed - Clinical trials for Autism Spectrum Disorder

Taekwondo for Children With Autism Spectrum Disorder

Start date: June 11, 2019
Phase: N/A
Study type: Interventional

This study uses a mixed methods design to understand the effectiveness of using taekwondo as an intervention for children with ASD and its effect on social interaction skills and everyday life. Qualitative research emphasizes that meaning can be explained and interpreted only by those who experience it. A pretest-posttest design will be used to describe what occurs after the introduction of the taekwondo intervention and understand the changes that occur after exposure. Collecting information through the lived experiences and observations from the parents will be collated with the pre and post results of the children participants' social interaction skills. Qualitative data will be collected through pre and post semi-structured interviews with the parents to understand their observations of their child before and after completing the taekwondo program. Interviews will also be conducted with the child to understand their perspectives on physical activity participation. Interview questions will also explore how the effectiveness of the program has impacted the children's engagement in daily activities. Quantitative research will be collected through pre and post results from the Autism Social Skills Profile-2 ([ASSP] assessment that will be completed by the parents. The ASSP-2 provides a comprehensive measure of social functioning for children and adolescents with ASD.

NCT ID: NCT03889821 Completed - Clinical trials for Autism Spectrum Disorder

Mindfulness Training and Parent-coaching Interventions for Autism Spectrum Disorder

Start date: March 11, 2015
Phase: N/A
Study type: Interventional

Caregivers of children with autism spectrum disorder (ASD) report higher levels of depression and distress than caregivers of typically developing children as well as children with other developmental disabilities. The proposed work tests a novel treatment paradigm that blends Mindfulness Based Stress Reduction (MBSR) with an empirically supported and manualized parent training program (Parent-Implemented Early Start Denver Model [P-ESDM]). We hypothesize that directly treating parental distress, while simultaneously providing evidence-based parent training, may greatly enhance child-focused intervention and provide benefits that resonate across the family.

NCT ID: NCT03887754 Completed - Clinical trials for Autism Spectrum Disorder

Therapeutic Issues for Autism

Start date: January 2016
Phase: Phase 2
Study type: Interventional

This study aimed to show the effects of hyperbaric oxygen therapy and/or Risperidone in improving symptoms of autism

NCT ID: NCT03883139 Recruiting - Clinical trials for Autism Spectrum Disorder

PRISM Intervention Study

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

This research study, Personalized, Responsive Intervention Sequences for Minimally Verbal Children with Autism (PRISM), is designed to maximize language outcomes for limited-language preschoolers, thereby lowering the risk of being classified as "minimally verbal" at age 6, by empirically developing a two-stage, 20-week adaptive intervention approach in a real world community settings. If found efficacious, the adaptive intervention design will capitalize on the heterogeneity and evolving status of children with ASD by providing the best intervention (DTT, JASPER and CET) for children who need it (leading to individualized sequences of intervention), only when it is needed (potentially reducing burden on children).

NCT ID: NCT03873831 Recruiting - Clinical trials for Autism Spectrum Disorder

Effects of Therapy Dogs on Social Behavior in Group Social Skills Instruction With Children With Autism

Start date: May 15, 2019
Phase: N/A
Study type: Interventional

Animal-Assisted Interventions (AAI) can increase social behavior in children with autism spectrum disorder (ASD), although the mechanism by which this occurs remains elusive. The central goal of this project is to identify the mechanisms involved in the social-enhancing effect of dogs on children with ASD. The investigators will incorporate therapy dogs into an established evidence-based, group social skills instruction program for children with ASD, using a controlled experimental design with between- and within- subject comparisons and physiological and behavioral outcome measures. The investigators predict therapy dogs to have a specific and measurable effect on children's social behavior and that this effect is gained through identifiable mechanisms. Specifically, the investigators hypothesize that (1) an integration of therapy dogs into group social skills instruction will result in reduced stress and improved social behavior compare to traditional group instruction; (2) repeated exposure to the therapy dog across sessions will increase a child's preference for spending time with the dog and will increase the social-enhancing effects of the dog; and (3) that the therapists will experience less stress, engage in more social and affiliative behavior towards the children, and deliver higher quality instruction during sessions that include dogs. The investigators will enroll 72 children with ASD into group social skills instruction classes taught by 6 therapists. Each child will experience a 10-week, 8-student class in which either (a) the first 5 weeks will involve a therapy dog, (b) the last 5 weeks will involve the therapy dog, or (c) the class will not involve a therapy dog. The therapists will teach the courses repeatedly across the three cycles of the program with different children, rotating through each condition. Social behavior, stress behavior, heart rate, electrodermal activity, and salivary cortisol concentrations of children and therapists will be assessed and compared across conditions. The direction of the children's social behavior towards the dog and peers and the changes in quality of instruction of therapists during dog sessions compared to no-dog sessions will also be assessed. The outcomes of this research will lead to significant enhancements in current interventions for individuals with ASD.

NCT ID: NCT03866668 Suspended - Clinical trials for Autism Spectrum Disorder

A Study of Esomeprazole in Children With Autism

Start date: May 29, 2019
Phase: Phase 2
Study type: Interventional

Autism is a pervasive developmental disorder characterized by core deficits in social behavior and communication and the presence of repetitive/stereotyped behaviors. The objective of the study is to evaluate the efficacy of Esomeprazole as a treatment for social communication deficits in children with Autism Spectrum Disorder (ASD). This prospective 12 week open-label study will invite 25 children with ASD between the ages of 2 and 6 years of age to participate.

NCT ID: NCT03865719 Completed - Clinical trials for Autism Spectrum Disorder

Weight Management Intervention for Youth and Young Adults With Autism Spectrum Disorder

ACORN-ASD
Start date: August 7, 2019
Phase: N/A
Study type: Interventional

Psychotropic medications are the first-line treatment across several diagnostic categories encompassing severe mood disturbances and behavioral problems. The use of Second Generation Antipsychotics (SGAs) has increased in children with Autism Spectrum Disorder (ASD) in the last decade. However, SGAs are associated with serious metabolic side effects in youth that include cardiovascular disease, hypertension, and diabetes mellitus. This makes the public health impact of treating medication-induced metabolic disturbances almost as important as treating the mental illness itself. Improving health and reducing premature mortality in people with severe mental illness, the investigators propose to provide early weight management prevention, delivered by clinicians, for youth starting SGAs in order to target common modifiable health risk factors in the developmental process. This study will provide an urgently needed practical model for integrating weight management into academic- and community-based autism care.

NCT ID: NCT03864289 Completed - Clinical trials for Autism Spectrum Disorder

Parent Skills Training for Families of Children With Autism Spectrum Disorder

Start date: March 15, 2019
Phase: N/A
Study type: Interventional

The study is focused on helping parents master the basic intervention skills and evaluate the effectiveness of this parental training style for children with autism spectrum disorder in China.